Filing summary
Issuer discrepancy: The request identifies TERAWULF INC., but the supplied filing is IKONICS Corporation’s Form 10-K. It covers the fiscal year ended December 31, 2013, not a standalone 2013 fourth-quarter report. The figures below summarize the supplied filing and should not be attributed to TeraWulf.
Business context and reporting period
IKONICS developed and manufactured photochemical imaging products, including screen-printing and abrasive-etching products, and was investing in industrial Micro-Machining and digital texturing (DTX) technologies. Its audited financial statements cover the years ended December 31, 2013 and 2012.
Financial performance and liquidity
| Metric | 2013 | 2012 |
|---|---|---|
| Net sales | $17.49 million | $17.31 million |
| Gross profit / margin | $6.94 million / 39.7% | $6.94 million / 40.1% |
| Operating income | $920,000 | $1.03 million |
| Net income | $682,000 | $694,000 |
| Diluted EPS | $0.34 | $0.35 |
| Cash from operating activities | $1.47 million | $1.18 million |
Sales increased 1.0%, while operating income declined about 11% and net income declined about 2%. SG&A was $5.37 million, up from $5.28 million; R&D was $649,000, versus $630,000. The 2013 effective tax rate was 26.4%, compared with 33.6% in 2012; the 2013 provision benefited from a research-and-development tax credit recognized after a tax-law change.
At year-end, cash and cash equivalents were $1.70 million and short-term investments were $1.46 million. Current assets were $8.05 million and current liabilities $875,000. Total liabilities were $1.40 million; the company reported no line-of-credit borrowings at year-end. Its available credit line was $1.25 million, subject to renewal in May 2015. Capital expenditures were $763,000 in 2013.
Material changes and unusual items
- Domestic, Export, and IKONICS Imaging sales increased; Micro-Machining mask sales fell 29.8%, partly due to the loss of a large customer. DTX sales fell 13.4%, reflecting a DTX printer sale in 2012 and none in 2013.
- Micro-Machining gross margin deteriorated from 5.3% to negative 54.5%, amid lower volume and higher production costs. Its operating loss widened to $635,000 from $289,000. DTX reported an operating loss of $138,000, close to the prior year’s $142,000 loss.
- IKONICS paid a one-time $1.00-per-share dividend totaling approximately $2.0 million in 2012; no dividend was paid in 2013.
- 2013 operating cash flow increased, supported in part by a $124,000 inventory reduction. Investing activities used $820,000, chiefly reflecting capital spending and certificate-of-deposit activity.
Outlook, commentary, and risks
Management planned approximately $600,000 of capital expenditures in 2014, primarily for elevator upgrades, manufacturing equipment, and vehicles, expected to be funded from operating cash flow. It planned to continue investing in R&D and capacity. Management cited aerospace feasibility work and existing supply activity as possible sources of future Micro-Machining business, while acknowledging potential effects from defense-budget sequestration and aircraft-program delays. DTX development included prototyping and 3D-printing applications; management gave no quantified revenue or earnings guidance.
Key risks include failure of DTX and Micro-Machining to gain market acceptance, continued losses in those businesses, competition and technology change, aerospace and automotive industry volatility, government-contractor delays and compliance obligations, reliance on distributors and limited-source suppliers, raw-material price or availability changes, environmental regulation, intellectual-property disputes, and international business risks. The filing reported no legal proceedings. The auditor issued an unqualified opinion on the financial statements; management assessed internal control over financial reporting as effective, without auditor attestation.
Important facts for investors to verify
- Confirm the issuer and filing: the supplied document is IKONICS Corporation’s 2013 Form 10-K, not a TeraWulf filing.
- Review the audited statements and segment disclosures, especially Micro-Machining’s sharply negative gross margin and operating loss.
- Assess whether the planned aerospace business, DTX commercialization, and 2014 capital spending translated into sustainable revenue and profitability.
- Check the status and renewal of the $1.25 million credit line, and the company’s cash and investment balances after year-end.
- Consider that the filing provides annual results, not separate fourth-quarter financial results or quantified forward guidance.